News und Analysen
![Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?: https://g.foolcdn.com/editorial/images/746425/biotech-laboratory-getty.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXlHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--985d73e0a0c399589b1a65d72023a1cd2c12f466/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/biotech-laboratory-getty.jpg?locale=de)
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
If you're trying to build a passive income stream to eventually fuel your dream retirement, Abbott Laboratories (NYSE: ABT) is a stock you probably want to know more about. This legendary dividend
![Why Insmed Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/746577/scientists-smiling-and-shaking-hands.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNHVHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e31f2b40eb73c38c81ab3e82193a8f47cd47a076/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientists-smiling-and-shaking-hands.jpg?locale=de)
Why Insmed Stock Is Soaring Today
Shares of Insmed (NASDAQ: INSM) were soaring 17.1% higher as of 11:27 a.m. ET on Tuesday. The big gain came after the company announced positive top-line results from its late-stage Arise clinical
![Competing in These 3 Markets Could Send Eli Lilly Stock Soaring: https://g.foolcdn.com/editorial/images/746164/a-young-scientist-recording-her-findings-on-a-tablet.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNEdHYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b607029441e3b68d4dd3e5ff623bc4c26d4152ec/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-young-scientist-recording-her-findings-on-a-tablet.jpg?locale=de)
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Unlike many of its big pharma peers, Eli Lilly (NYSE: LLY) is a growth stock that's likely to maintain a faster-than-average pace of expansion over the next few years. Between its massive portfolio
![Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?: https://g.foolcdn.com/editorial/images/746381/gettyimages-1300117942.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN2FGYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d8d4302e64a344e526e9efd6e995399d81cf3021/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettyimages-1300117942.jpg?locale=de)
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
Though the pandemic isn't over, people haven't been rushing out to get coronavirus vaccines these days. This spring, the international public health emergency came to an end, and it looked as if we
![3 Reasons to Buy Pfizer Stock: https://g.foolcdn.com/editorial/images/746031/patient-talking-with-a-physician.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeU9GYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--130e2dab97e2334fe6708b659e7e7f3f011dce85/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/patient-talking-with-a-physician.jpg?locale=de)
3 Reasons to Buy Pfizer Stock
Many investors are having a hard time finding good reasons to invest in Pfizer (NYSE: PFE) right now, at least if we go by the company's performance in the stock market this year. Pfizer's shares
![Could CVS Make a Copy of Ozempic?: https://g.foolcdn.com/editorial/images/746168/pharmacist-works-in-back-of-pharmacy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOW1FYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8b0335f96b68e344ea2ece08ef458f2244d70f1e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/pharmacist-works-in-back-of-pharmacy.jpg?locale=de)
Could CVS Make a Copy of Ozempic?
On Aug. 23, CVS Health (NYSE: CVS) made waves when it announced that it will be launching a new business called Cordavis that will be devoted to commercializing biosimilar medicines. If you aren't
![Trupanion's Membership Is Soaring. Should You Buy the Stock?: https://g.foolcdn.com/editorial/images/745924/a-veterinarian-examines-a-cat.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTZFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--01ec9568b94b6d03df70d3f140ac21e87830dcc2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-veterinarian-examines-a-cat.jpg?locale=de)
Trupanion's Membership Is Soaring. Should You Buy the Stock?
As a growth investor, few signs are as encouraging to witness from one of your holdings as a rapidly growing customer base. This is because such an occurrence typically means that the revenue of a
![3 No-Brainer Dividend Stocks to Buy in September: https://g.foolcdn.com/editorial/images/746158/dividend-income.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--07e7b58fb928834f9a0b3b95ec3e3e90775fe5e7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/dividend-income.jpg?locale=de)
3 No-Brainer Dividend Stocks to Buy in September
When's a good time to invest in dividend stocks? Any month that has a vowel in its name.
We asked three Motley Fool contributors to identify no-brainer dividend stocks to buy in September. Here's
![Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?: https://g.foolcdn.com/editorial/images/746165/a-doctor-examines-a-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOVNFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3c29bc370e91195a71a3df3595853981bfe914a0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-doctor-examines-a-patient.jpg?locale=de)
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
The aim of growth investing is to build significant wealth. Targeting companies that are briskly growing revenue can be a lucrative approach to investing.
In the past five years, the genetic
![Why Catalent Stock Zoomed 12% Higher This Week: https://g.foolcdn.com/editorial/images/746365/medical-professional-holding-dollar-sign-paperweight.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnFFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c135ed1c1d7b2602c48cdd2c6d69727992cf7464/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/medical-professional-holding-dollar-sign-paperweight.jpg?locale=de)
Why Catalent Stock Zoomed 12% Higher This Week
Catalent (NYSE: CTLT) is one company that probably wishes the summer would never end. As August came to a close, the contract drug manufacturer's stock enjoyed a nearly 12% rise over the course of
![Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: https://g.foolcdn.com/editorial/images/746251/gettymoneyraining.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMXVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c6ba0870d1ca86b7bb3efc8ddb145cf85a5968dc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettymoneyraining.jpg?locale=de)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
There is some good news and bad news for fans of Cathie Wood. The good news for the co-founder CEO of the Ark Invest family of exchange-traded funds (ETFs) is that her largest fund -- with more than
![CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know: https://g.foolcdn.com/editorial/images/745853/worried-investor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekdFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f69c3ec1fb62c95e2add9e950cf14f8b7f6e18c5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/worried-investor.jpg?locale=de)
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
On Aug. 23, CVS Health (NYSE: CVS) announced that it's launching a new subsidiary focused on biosimilar drugs. That business, Cordavis, will start by seeking to commercialize a biosimilar to
![3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy: https://g.foolcdn.com/editorial/images/746204/gettyimages-663845678.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3lEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--788248e4366094f3b9dc16c2b5376ae94d95c189/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettyimages-663845678.jpg?locale=de)
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
Every quarter, investors get excited for companies to report earnings. Some want the updated numbers that management teams share. Others are more curious to hear about plans and projections
![Looking for Dividend Growth? Buy This Little-Known Healthcare Stock: https://g.foolcdn.com/editorial/images/746040/a-healthcare-professional-draws-blood-from-a-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWVEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--eeb25785d49ffe7dbbdd94eba83e68d03c3c70a2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-healthcare-professional-draws-blood-from-a-patient.jpg?locale=de)
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
If you consider yourself a dividend investor, asking yourself the following question may aid in your success: What separates the wheat from the chaff among dividend stocks? Such a question gets you
![Here's Why the Next 4 Months May Be Critical for Pfizer: https://g.foolcdn.com/editorial/images/746115/gettyimages-871223262.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOXFEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2efeaeeaaf0d3fe5efd090497ed74eb544f0deab/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/gettyimages-871223262.jpg?locale=de)
Here's Why the Next 4 Months May Be Critical for Pfizer
Pfizer (NYSE: PFE) offered investors certainty in the earlier stages of the pandemic. People were clamoring for coronavirus vaccines and treatments, and Pfizer became a leader in both markets. Its
![Why Novocure Stock Fell 24.4% This Week: https://g.foolcdn.com/editorial/images/746187/doctor-examines-cancer-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN0tEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ae8111bd610abe6a74b59a5e21bc5696d1c2ce3b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/doctor-examines-cancer-patient.jpg?locale=de)
Why Novocure Stock Fell 24.4% This Week
Shares of Novocure (NASDAQ: NVCR) are down 25.9% so far this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence, as the company announced a
![Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot?: https://g.foolcdn.com/editorial/images/745591/a-person-receiving-a-vaccine-in-a-hospital-setting.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBem1EYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3a456484955b672d86c54b23d367d070ffda9413/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/a-person-receiving-a-vaccine-in-a-hospital-setting.jpg?locale=de)
Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot?
Concerns around COVID-19 are diminishing but they are not going away entirely. New variants are emerging and case numbers have been climbing.
One company that continues to work on developing an
![Is This the Green Light Biotech Stocks Have Been Waiting For?: https://g.foolcdn.com/editorial/images/745808/3-frowning-people-looking-at-a-laptop.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN3FDYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--05ea46d9ca716821ad09f1de59fe7c3f8a5ebdf6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/3-frowning-people-looking-at-a-laptop.jpg?locale=de)
Is This the Green Light Biotech Stocks Have Been Waiting For?
Are you a biotech investor who feels left behind? You're not alone. The broad Nasdaq Composite index has gained 13.7% since mid-May, but the Nasdaq Biotechnology index fell slightly over the same
![Why Insulet Stock Rocked the Market Today: https://g.foolcdn.com/editorial/images/746062/medical-professionals-conferring-in-a-hospial-corridor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHFDYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e4dd9e7939e563e725a0701affafd256fc788d7c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/medical-professionals-conferring-in-a-hospial-corridor.jpg?locale=de)
Why Insulet Stock Rocked the Market Today
Medical device maker Insulet's (NASDAQ: PODD) stock was the cure for the investor blues on Wednesday. Following news of a large insider buy, the shares subsequently shot more than 6% higher on the
![Why Patterson Companies Stock Dropped Today: https://g.foolcdn.com/editorial/images/745983/veterinarian-cat-sick-pet-health.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2VDYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--084b473ecff224d81b1425f20725bf72082bd90e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/veterinarian-cat-sick-pet-health.jpg?locale=de)
Why Patterson Companies Stock Dropped Today
Shares of Patterson Companies (NASDAQ: PDCO) fell as much as 14.2% early Wednesday, then partially recovered to trade down 5.6% as of 11.50 a.m. EDT after the company announced slightly
![The Top Healthcare Stocks to Buy With $100: https://g.foolcdn.com/editorial/images/745504/person-sitting-and-working-at-a-desk.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNitCYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b1780bd0c6ffc0fe51257ae873dfcb7f56515777/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/person-sitting-and-working-at-a-desk.jpg?locale=de)
The Top Healthcare Stocks to Buy With $100
Investing in stocks isn't just for the rich and famous since quality stocks can be found at almost any price. Some are trading for well above $1,000 per share, while others go for less than $100
![Why Catalent Stock Surged Nearly 5% Higher Today: https://g.foolcdn.com/editorial/images/745913/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFNCYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a42528c8a15fb8f297c112721502f684df5aecf0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg?locale=de)
Why Catalent Stock Surged Nearly 5% Higher Today
Contract drug manufacturer Catalent (NYSE: CTLT) provided some very effective medicine to its investors on Tuesday. The company's shares leaped almost 5% higher following the publication of its
![Better Buy: Biogen vs. Eli Lilly: https://g.foolcdn.com/editorial/images/745461/elderly-person-sitting-on-a-bed.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNytBYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8942c57ff385ea3f652b90b6dbd90929cf773976/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/elderly-person-sitting-on-a-bed.jpg?locale=de)
Better Buy: Biogen vs. Eli Lilly
Biogen (NASDAQ: BIIB) and Eli Lilly (NYSE: LLY) have a lot in common. Both companies are among the leaders in the biotech industry. Both have deep lineups and pipelines. And both are looking to
![Nearing Retirement? These Stocks Will Pay You For Life: https://g.foolcdn.com/editorial/images/745116/physician-talking-to-patient.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkNBYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3434afedede47a8006324a6de439229de62f5103/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/physician-talking-to-patient.jpg?locale=de)
Nearing Retirement? These Stocks Will Pay You For Life
While government programs help retirees replace some of their income once they stop working, these initiatives aren't meant to fund all of people's expenses in their golden years. That's why many
![Why Novavax Stock Was So Healthy on Monday: https://g.foolcdn.com/assets/images/fool/tmf-logo_400x400.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaTRFIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--7b1053a3605f66e35a9c178293b2594f08cb4204/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/tmf-logo_400x400.png?locale=de)
Why Novavax Stock Was So Healthy on Monday
The latest rise in COVID-19 statistics is bringing investors back to coronavirus stocks. That, combined with a top-down effort to develop an updated vaccine and get it in the arms of as many